General

Pfizer paid $2.3 billion in 2009. GlaxoSmithKline paid $3 billion in 2012. AstraZeneca paid $520 million in 2010. Each of […]

On September 30, 2004, Merck pulled Vioxx from every pharmacy shelf in the world. The withdrawal took less than 24

There’s a repeating theme across DrugChatter: not “what are the side effects?” but “is this normal—or something I should worry

There’s a quiet sorting mechanism in medicine that has little to do with pharmacology textbooks and everything to do with

If you spend enough time around athletes, weekend warriors, or anyone optimizing “fitness,” you start to notice a recurring theme:

Every so often the public conversation about medicines drifts into a familiar question: why is this one so expensive? But

Chatbots now answer drug questions that once required a detail rep, a pharmacist, or a Medical Information call center. The

AI Agents Now Influence Which Drugs Patients Ask For — Here’s the Pharma Playbook When a patient with newly diagnosed

AI Pharmacovigilance: How Drug Companies Track Safety Signals Before Regulators Do The FDA receives roughly 2 million adverse event reports

The channel shift is not hypothetical. Patients and prescribers are asking AI chatbots about drug dosing, side effects, and alternatives

Spend enough time watching patient questions, and a pattern emerges: it’s not just “does this work?” or “is this safe?”—it’s

If you want to understand drug shortages, don’t start with FDA dashboards. Start with patient questions. They don’t say “supply